Buffalo Startups and VC Firms in 2026: ACV Auctions, 43North, and Life Sciences Capital
Buffalo’s venture map in 2026 — ACV Auctions (NASDAQ: ACVA), Guidesly, PostProcess, Roswell/UB spinouts, plus 43North, Launch NY, and Rand Capital.
Venture capital fuels the companies that reshape industries — from AI infrastructure and fintech to healthcare and defense tech. This hub collects our latest analysis on how VC firms evaluate startups, structure deals, and deploy capital across stages and geographies.
Browse the articles below to research investors, understand deal dynamics, and build a sharper fundraising strategy.
Buffalo’s venture map in 2026 — ACV Auctions (NASDAQ: ACVA), Guidesly, PostProcess, Roswell/UB spinouts, plus 43North, Launch NY, and Rand Capital.
As of July 2026, the Boston–Cambridge funds we cover — General Catalyst, Battery, Third Rock, Atlas, CRV, F-Prime, Spark — plus when ARCH shows up on East Coast biotech caps.
As of July 2026, directory companies we can honestly place in Boston–Cambridge or Greater Boston — plus related biotech coverage tied to Boston capital with HQ labeled elsewhere.
Boise's venture map in 2026 — Clearwater Analytics (NYSE: CWAN), Lovevery, GetWhys, OurPetPolicy's Series A, and three local capital paths beyond Capital Eleven alone.
Birmingham, Alabama’s venture map in 2026 — Shipt’s $550M Target exit, Acclinate and ArcheHealth raises, UAB spinouts, and the local funds that write first checks.
Baltimore venture map in 2026 — TEDCO, Latimer, TCP, Maryland Momentum, plus kweliTV, Bayesian Health, Pearl Diagnostics, Inner Logic, and Neurava.